Year |
Citation |
Score |
2014 |
Pica N, Bouvier NM. Ambient temperature and respiratory virus infection. The Pediatric Infectious Disease Journal. 33: 311-3. PMID 24378933 DOI: 10.1097/Inf.0000000000000235 |
0.471 |
|
2013 |
Krammer F, Pica N, Hai R, Margine I, Palese P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. Journal of Virology. 87: 6542-50. PMID 23576508 DOI: 10.1128/Jvi.00641-13 |
0.796 |
|
2013 |
Pica N, Palese P. Toward a universal influenza virus vaccine: prospects and challenges. Annual Review of Medicine. 64: 189-202. PMID 23327522 DOI: 10.1146/Annurev-Med-120611-145115 |
0.745 |
|
2012 |
Krammer F, Margine I, Tan GS, Pica N, Krause JC, Palese P. A carboxy-terminal trimerization domain stabilizes conformational epitopes on the stalk domain of soluble recombinant hemagglutinin substrates. Plos One. 7: e43603. PMID 22928001 DOI: 10.1371/Journal.Pone.0043603 |
0.783 |
|
2012 |
Krammer F, Pica N, Hai R, Tan GS, Palese P. Hemagglutinin Stalk-Reactive Antibodies Are Boosted following Sequential Infection with Seasonal and Pandemic H1N1 Influenza Virus in Mice. Journal of Virology. 86: 10302-7. PMID 22787225 DOI: 10.1128/Jvi.01336-12 |
0.8 |
|
2012 |
Pica N, Langlois RA, Krammer F, Margine I, Palese P. NS1-truncated live attenuated virus vaccine provides robust protection to aged mice from viral challenge. Journal of Virology. 86: 10293-301. PMID 22787224 DOI: 10.1128/Jvi.01131-12 |
0.787 |
|
2012 |
Bouvier NM, Rahmat S, Pica N. Enhanced mammalian transmissibility of seasonal influenza A/H1N1 viruses encoding an oseltamivir-resistant neuraminidase. Journal of Virology. 86: 7268-79. PMID 22532693 DOI: 10.1128/Jvi.07242-12 |
0.53 |
|
2012 |
Pica N, Bouvier NM. Environmental factors affecting the transmission of respiratory viruses. Current Opinion in Virology. 2: 90-5. PMID 22440971 DOI: 10.1016/J.Coviro.2011.12.003 |
0.403 |
|
2012 |
Maamary J, Pica N, Belicha-Villanueva A, Chou YY, Krammer F, Gao Q, García-Sastre A, Palese P. Attenuated influenza virus construct with enhanced hemagglutinin protein expression. Journal of Virology. 86: 5782-90. PMID 22398291 DOI: 10.1128/Jvi.00190-12 |
0.801 |
|
2012 |
Hai R, Krammer F, Tan GS, Pica N, Eggink D, Maamary J, Margine I, Albrecht RA, Palese P. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. Journal of Virology. 86: 5774-81. PMID 22398287 DOI: 10.1128/Jvi.00137-12 |
0.743 |
|
2012 |
Pica N, Hai R, Krammer F, Wang TT, Maamary J, Eggink D, Tan GS, Krause JC, Moran T, Stein CR, Banach D, Wrammert J, Belshe RB, García-Sastre A, Palese P. Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proceedings of the National Academy of Sciences of the United States of America. 109: 2573-8. PMID 22308500 DOI: 10.1073/Pnas.1200039109 |
0.811 |
|
2012 |
Pica N, Chou YY, Bouvier NM, Palese P. Transmission of influenza B viruses in the guinea pig. Journal of Virology. 86: 4279-87. PMID 22301149 DOI: 10.1128/Jvi.06645-11 |
0.795 |
|
2011 |
Pica N, Iyer A, Ramos I, Bouvier NM, Fernandez-Sesma A, GarcÃa-Sastre A, Lowen AC, Palese P, Steel J. The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses. Journal of Virology. 85: 12825-9. PMID 21917963 DOI: 10.1128/Jvi.05930-11 |
0.763 |
|
2011 |
Chou YY, Albrecht RA, Pica N, Lowen AC, Richt JA, García-Sastre A, Palese P, Hai R. The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. Journal of Virology. 85: 11235-41. PMID 21880744 DOI: 10.1128/Jvi.05794-11 |
0.817 |
|
2011 |
Pica N, Palese P, Steel J. Live attenuated influenza virus vaccines: Ns1 truncation as an approach to virus attenuation Birkhauser Advances in Infectious Diseases. 195-221. DOI: 10.1007/978-3-0346-0277-8_8 |
0.76 |
|
2010 |
Wang TT, Tan GS, Hai R, Pica N, Ngai L, Ekiert DC, Wilson IA, García-Sastre A, Moran TM, Palese P. Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proceedings of the National Academy of Sciences of the United States of America. 107: 18979-84. PMID 20956293 DOI: 10.1073/Pnas.1013387107 |
0.828 |
|
2010 |
Wang TT, Tan GS, Hai R, Pica N, Petersen E, Moran TM, Palese P. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. Plos Pathogens. 6: e1000796. PMID 20195520 DOI: 10.1371/Journal.Ppat.1000796 |
0.805 |
|
2009 |
Kopecky-Bromberg SA, Fraser KA, Pica N, Carnero E, Moran TM, Franck RW, Tsuji M, Palese P. Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine. 27: 3766-74. PMID 19464560 DOI: 10.1016/J.Vaccine.2009.03.090 |
0.727 |
|
Show low-probability matches. |